Literature DB >> 7912223

Anti-CD4 treatment of NZB mice prevents the development of erythrocyte autoantibodies but hastens the appearance of anaemia.

G G Oliveira1, P R Hutchings, P M Lydyard.   

Abstract

New Zealand Black (NZB) mice spontaneously develop autoimmune haemolytic anaemia as the result of production of autoantibodies to erythrocytes. We have recently shown that antibodies to CD4 prevent the development of erythrocyte autoantibodies in young mice (Coombs' negative). In spite of this inhibition of erythrocyte autoantibody production, the anti-CD4-treated mice show a precocious and severe anaemia. Balb/c mice treated with the same protocol do not develop anaemia. Our results suggest that erythropoiesis in NZB mice is particularly sensitive to depletion of CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912223     DOI: 10.1016/0165-2478(94)90100-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  1 in total

1.  Long-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.

Authors:  Geraldo Gs Oliveira; John Holton; Peter M Lydyard
Journal:  Gut Microbes       Date:  2010-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.